Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Breast Cancer Res Treat ; 205(3): 439-449, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38517603

RESUMEN

PURPOSE: For breast cancer survivors (BCS) living with breast cancer-related lymphedema (BCRL), what outcome measures (OMs) are recommended to be used to measure standardized outcome domains to fully assess the burden of the disease and efficacy of interventions? An integral component of a standardized core outcome set (COS) are the OMs used to measure the COS. METHODS: A supplemental online survey was linked to a Delphi study investigating a COS for BCRL. OMs were limited to a maximum of 10 options for each outcome domain (OD). There were 14 ODs corresponding to the International Classification of Functioning, Disability, and Health (ICF) framework and respondents rated the OMs with a Likert level of recommendation. The feasibility of the listed OMs was also investigated for most outpatient, inpatient, and research settings. RESULTS: This study identified 27 standardized OMs with a few ODs having 2-3 highly recommended OMs for proper measurement. A few of the recommended OMs have limitations with reliability due to being semi-quantitative measures requiring the interpretation of the rater. CONCLUSION: Narrowing the choices of OMs to 27 highly recommended by BCRL experts may reduce selective reporting, inconsistency in clinical use, and variability of reporting across interdisciplinary healthcare fields which manage or research BCRL. There is a need for valid, reliable, and feasible OMs that measure tissue consistency. Measures of upper extremity activity and motor control need further research in the BCS with BCRL population.


Asunto(s)
Linfedema del Cáncer de Mama , Supervivientes de Cáncer , Técnica Delphi , Evaluación de Resultado en la Atención de Salud , Humanos , Femenino , Linfedema del Cáncer de Mama/terapia , Linfedema del Cáncer de Mama/diagnóstico , Linfedema del Cáncer de Mama/etiología , Evaluación de Resultado en la Atención de Salud/métodos , Neoplasias de la Mama/complicaciones , Encuestas y Cuestionarios , Calidad de Vida , Persona de Mediana Edad , Reproducibilidad de los Resultados
2.
Breast Cancer Res Treat ; 205(2): 359-370, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38424364

RESUMEN

PURPOSE: For breast cancer survivors (BCS) living with breast cancer-related lymphedema (BCRL), what outcome domains (OD) should be measured to assess the burden of the disease and efficacy of interventions? A Core Outcome Set (COS) that promotes standardized measurement of outcomes within the constraints of time influenced by work environments is essential for patients and the multidisciplinary professionals that manage and research BCRL. METHODS: Using Delphi methodology, a multidisciplinary group of BCRL experts (physical and occupational therapists, physicians, researchers, physical therapist assistants, nurses, and massage therapist) completed two waves of online surveys. BCRL expert respondents that completed the first survey (n = 78) had an average of 26.5 years in practice, whereas, respondents who completed the second survey (n = 33) had an average of 24.9 years. ODs were included in the COS when consensus thresholds, ranging from 70% to 80%, were met. RESULTS: A total of 12 ODs made up the COS. Reaching a minimum consensus of 70%; volume, tissue consistency, pain, patient-reported upper quadrant function, patient-reported health-related quality of life, and upper extremity activity and motor control were recommended at different phases of the BCRL continuum in a time-constrained environment. Joint function, flexibility, strength, sensation, mobility and balance, and fatigue met an 80% consensus to be added when time and resources were not constrained. CONCLUSION: The COS developed in this study thoroughly captures the burden of BCRL. Using this COS may reduce selective reporting, inconsistency in clinical use, and variability of reporting across interdisciplinary healthcare fields, which manage or research BCRL.


Asunto(s)
Linfedema del Cáncer de Mama , Supervivientes de Cáncer , Técnica Delphi , Calidad de Vida , Humanos , Femenino , Linfedema del Cáncer de Mama/terapia , Linfedema del Cáncer de Mama/etiología , Neoplasias de la Mama/complicaciones , Encuestas y Cuestionarios , Medición de Resultados Informados por el Paciente , Evaluación de Resultado en la Atención de Salud/métodos , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda